A Comprehensive, Multi-Scale Dynamical Model of ErbB Receptor Signal Transduction in Human Mammary Epithelial Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Helikar, Tomáš ^a   Kochi, Naomi ^a   Kowal, Bryan ^a   Dimri, Manjari ^b   Naramura, Mayumi ^c,d   Raja, Srikumar M ^c   Band, Vimla ^c,d   Band, Hamid ^c,d   Rogers, Jim A ^a,d  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; INTEGRIN; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST EPITHELIUM; COMPUTER MODEL; COMPUTER PREDICTION; COMPUTER SIMULATION; CONTROLLED STUDY; ENDOCYTOSIS; INTERNALIZATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

BREAST; COMPUTER SIMULATION; ENDOCYTOSIS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; HUMANS; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84876337178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061757     Document Type: Article

References (57)

1. Hynes NE, Lane HA, (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nature reviews Cancer 5: 341-354 doi:10.1038/nrc1609.
2. Hynes NE, MacDonald G, (2009) ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 21: 177-184.
3. Stern DF, (2000) Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases. Breast Cancer Res 2: 176-183.
4. Yarden Y, (2001) Biology of HER2 and its importance in breast cancer. Oncology 61 (Suppl 2):: 1-13.
5. Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF 3rd, et al. (2003) The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci U S A 100: 8933-8938.
6. Yarden Y, Sliwkowski MX, (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
7. Sorkin A, Von Zastrow M, (2009) Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10: 609-622.
8. Wertheimer E, Gutierrez-Uzquiza A, Rosemblit C, Lopez-Haber C, Sosa MS, et al. (2012) Rac signaling in breast cancer: a tale of GEFs and GAPs. Cellular signalling 24: 353-362 doi:10.1016/j.cellsig.2011.08.011.
9. Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ, (2000) Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res 2: 203-210.
10. Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ, (1995) Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proceedings of the National Academy of Sciences of the United States of America 92: 6981-6985.
11. Dimri M, Naramura M, Duan L, Chen J, Ortega-Cava C, et al. (2007) Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer research 67: 4164-4172 doi:10.1158/0008-5472.CAN-06-2580.
12. Wheeler DL, Iida M, Dunn EF, (2009) The role of Src in solid tumors. Oncologist 14: 667-678.
13. Wiley HS, Shvartsman SY, Lauffenburger DA, (2003) Computational modeling of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol 13: 43-50.
14. Shankaran H, Wiley HS, Resat H, (2007) Receptor downregulation and desensitization enhance the information processing ability of signalling receptors. BMC Syst Biol 1: 48.
15. Gex-Fabry M, DeLisi C, (1984) Receptor-mediated endocytosis: a model and its implications for experimental analysis. Am J Physiol 247: R768-79.
16. Wiley HS, Cunningham DD, (1981) A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands. Cell 25: 433-440.
17. Wiley HS, Cunningham DD, (1982) The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. J Biol Chem 257: 4222-4229.
18. Hendriks BS, Orr G, Wells A, Wiley HS, Lauffenburger DA, (2005) Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells. J Biol Chem 280: 6157-6169.
19. Hendriks BS, Opresko LK, Wiley HS, Lauffenburger D, (2003) Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. Cancer Res 63: 1130-1137.
20. Shankaran H, Wiley HS, Resat H, (2006) Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response. Biophys J 90: 3993-4009.
21. Knauer DJ, Wiley HS, Cunningham DD, (1984) Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system. J Biol Chem 259: 5623-5631.
22. Starbuck C, Lauffenburger DA, (1992) Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Biotechnol Prog 8: 132-143.
23. Waters CM, Overholser KA, Sorkin A, Carpenter G, (1992) Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism. J Cell Physiol 152: 253-263.
24. Bhalla US, Iyengar R, (1999) Emergent properties of networks of biological signaling pathways. Science 283: 381-387.
25. Kholodenko BN, Demin O V, Moehren G, Hoek JB, (1999) Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 274: 30169-30181.
26. Haugh JM, Huang AC, Wiley HS, Wells A, Lauffenburger DA, (1999) Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem 274: 34350-34360.
27. Schoeberl B, Eichler-Jonsson C, Gilles ED, Müller G, (2002) Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 20: 370-375.
28. Wang DYQ, Cardelli L, Phillips A, Piterman N, Fisher J, (2009) Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics. BMC Syst Biol 3: 118.
29. Samaga R, Saez-Rodriguez J, Alexopoulos LG, Sorger PK, Klamt S, (2009) The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data. PLoS Comput Biol 5: e1000438.
30. Sahin O, Fröhlich H, Löbke C, Korf U, Burmester S, et al. (2009) Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance. BMC Syst Biol 3: 1.
31. Helikar T, Rogers JA, (2009) ChemChains: a platform for simulation and analysis of biochemical networks aimed to laboratory scientists. BMC Syst Biol 3: 58.
32. Helikar T, Kowal B, McClenathan S, Bruckner M, Rowley T, et al. (2012) The Cell Collective: Toward an open and collaborative approach to systems biology. BMC systems biology 6: 96 doi:10.1186/1752-0509-6-96.
33. Finney A, Hucka M, (2003) Systems biology markup language: Level 2 and beyond. Biochemical Society transactions 31: 1472-1473 doi:10.1042/.
34. Helikar T, Konvalina J, Heidel J, Rogers JA, (2008) Emergent decision-making in biological signal transduction networks. Proc Natl Acad Sci U S A 105: 1913-1918.
35. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, et al. (1996) A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 16: 5276-5287.
36. Ware MF, Tice DA, Parsons SJ, Lauffenburger DA, (1997) Overexpression of cellular Src in fibroblasts enhances endocytic internalization of epidermal growth factor receptor. J Biol Chem 272: 30185-30190.
37. Sorkin A, Goh LK, (2008) Endocytosis and intracellular trafficking of ErbBs. Experimental cell research 314: 3093-3106 doi:10.1016/j.yexcr.2008.08.013.
38. Roepstorff K, Grøvdal L, Grandal M, Lerdrup M, Van Deurs B, (2008) Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Histochemistry and cell biology 129: 563-578 doi:10.1007/s00418-008-0401-3.
39. Zwang Y, Yarden Y, (2009) Systems biology of growth factor-induced receptor endocytosis. Traffic (Copenhagen, Denmark) 10: 349-363 doi:10.1111/j.1600-0854.2008.00870.x.
40. Chung BM, Raja SM, Clubb RJ, Tu C, George M, et al. (2009) Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src. BMC cell biology 10: 84 doi:10.1186/1471-2121-10-84.
41. Chung BM, Dimri M, George M, Reddi AL, Chen G, et al. (2009) The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene 28: 1821-1832 doi:10.1038/onc.2009.31.
42. Di Ventura B, Lemerle C, Michalodimitrakis K, Serrano L, (2006) From in vivo to in silico biology and back. Nature 443: 527-533.
43. Todd RG, Helikar T, (2012) Ergodic sets as cell phenotype of budding yeast cell cycle. PloS one 7: e45780 doi:10.1371/journal.pone.0045780.
44. Madrahimov A, Helikar T, Kowal B, Lu G, Rogers J, (2012) Dynamics of Influenza Virus and Human Host Interactions During Infection and Replication Cycle. Bulletin of mathematical biology In press. doi:10.1007/s11538-012-9777-2.
45. Morris MK, Saez-Rodriguez J, Sorger PK, Lauffenburger DA, (2010) Logic-based models for the analysis of cell signaling networks. Biochemistry 49: 3216-3224 doi:10.1021/bi902202q.
46. Helikar T, Kochi N, Konvalina J, Rogers JA, (2011) Boolean Modeling of Biochemical Networks. The Open Bioinformatics Journal 4: 16-25.
47. Helikar T, Kowal B, Madrahimov A, Shrestha M, Pedersen J, et al. (2012) Bio-logic builder: a non-technical tool for building dynamical, qualitative models. PloS one 7: e46417 doi:10.1371/journal.pone.0046417.
48. Zhao X, Malhotra GK, Lele SM, Lele MS, West WW, et al. (2010) Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate. Proceedings of the National Academy of Sciences of the United States of America 107: 14146-14151 doi:10.1073/pnas.1009030107.
49. Ratsch SB, Gao Q, Srinivasan S, Wazer DE, Band V, (2001) Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells. Radiation research 155: 143-150.
50. Dimri M, Naramura M, Duan L, Chen J, Ortega-Cava C, et al. (2007) Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer research 67: 4164-4172 doi:10.1158/0008-5472.CAN-06-2580.
51. Band V, Sager R, (1989) Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proceedings of the National Academy of Sciences of the United States of America 86: 1249-1253.
52. Roux PP, Blenis J, (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiology and molecular biology reviews: MMBR 68: 320-344 doi:10.1128/MMBR.68.2.320-344.2004.
53. Sridhar SS, Hedley D, Siu LL, (2005) Raf kinase as a target for anticancer therapeutics. Molecular cancer therapeutics 4: 677-685 doi:10.1158/1535-7163.MCT-04-0297.
54. Edin ML, Juliano RL, (2005) Raf-1 serine 338 phosphorylation plays a key role in adhesion-dependent activation of extracellular signal-regulated kinase by epidermal growth factor. Molecular and cellular biology 25: 4466-4475 doi:10.1128/MCB.25.11.4466-4475.2005.
55. Price LS, Leng J, Schwartz MA, Bokoch GM, (1998) Activation of Rac and Cdc42 by integrins mediates cell spreading. Molecular biology of the cell 9: 1863-1871.
56. Selbie LA, Hill SJ, (1998) G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends in pharmacological sciences 19: 87-93.
57. Milligan G, White JH, (2001) Protein-protein interactions at G-protein-coupled receptors. Trends in pharmacological sciences 22: 513-518.